Clinical Trials

Clinical Trials

Fostamatinib - AIHA

A Phase 2, open-label (active only), multi-center clinical study of fostamatinib disodium in the treatment of warm antibody autoimmune hemolytic anemia (AIHA). The purpose of this study is to determine whether fostamatinib is safe and effective in the treatment of AIHA.

Phase 2 - AIHA

Fostamatinib - IgA Nephropathy:

A Phase 2, multi-center, randomized, double-blind, ascending-dose, placebo-controlled clinical study of fostamatinib disodium in the treatment of IgA Nephropathy (IgAN). The purpose of this study is to determine whether fostamatinib is safe and effective in the treatment of IgAN.

Phase 2 - IgA Nephropathy